Seoul National University Hospital
Seoul, 110-744, South Korea
NCT Number: NCT01203137
Preoperative right ventricular end-systolic area (RV-ESA) and hemoglobin level were suggested as independent prognosticator for predicting long-term prognosis in patients with isolated severe TR undergoing corrective surgery We attempted to explore whether early postoperative echocardiography provides additional prognostic information on top of preoperative clinical and echocardiographic variables.
Looking for future studies?
Notify Me21 year–80 year
All sexes
Observational
Seoul, 110-744, South Korea
We prospectively recruited patients with isolated severe TR undergoing corrective surgery. Comprehensive preoperative echocardiography was performed in all patients, with the performance of early postoperative echocardiography in all patients. During follow-up, clinical events, defined as operative mortality (death within 30 days after surgery or before discharge), cardiovascular death, repeated open heart surgery, and readmission due to cardiovascular problems were investigated.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 40 months
Clinical events were defined as operative mortality (death within 30 days after surgery or before discharge), cardiovascular death, repeated open heart surgery, and readmission due to cardiovascular problems.
Seoul National University Hospital
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03745313
Cardiovascular Diseases, Deglutition Disorders
Los Angeles, California, United States
View Trial DetailsNCT02339974
Cardiovascular Diseases, Heart Diseases
Detroit, Michigan, United States
View Trial DetailsNCT06343363
Cardiovascular Diseases, Heart Diseases
Oxford, Oxfordshire, United Kingdom
View Trial DetailsNCT05436028
Cardiovascular Diseases, Heart Diseases
Bordeaux, Gironde, France
View Trial Details